Published Jul 8, 2021

Psychedelics with Sam Harris

Sam Harris delves into psychedelics' potential to unlock deep insights and explores ethical living amidst modern challenges, while Scott Galloway analyzes how big tech could revolutionize healthcare, spotlighting companies like Amazon and Walmart in making healthcare more accessible.
Episode Highlights
The Prof G Pod with Scott Galloway logo

Popular Clips

Episode Highlights

  • Personal Journeys

    shares his personal journey with psychedelics, highlighting both the motivations and outcomes of his experiences. He describes how significant doses of psilocybin can lead to profound insights, akin to "rebooting the hard drive," offering therapeutic effects but also potential for intense, unpleasant experiences 1. Sam emphasizes the importance of having a guide to help reframe negative experiences, reducing the risk of adverse effects 2. He reflects on his recent psilocybin experience, noting it would have been one of the most significant of his life had he not already integrated previous experiences through meditation 3.

       

    Microdosing

    Microdosing, as explains, involves taking small doses of psychedelics like LSD and psilocybin, which are physiologically benign and can have antidepressant effects 4. Unlike full doses, microdosing doesn't alter perception significantly but can subtly enhance mood and focus. Sam notes that while microdosing is popular, most research is anecdotal, with many people reporting positive experiences 5.

       

    Risk Management

    Managing the risks associated with psychedelics is crucial, as points out. He likens psychedelic experiences to a "spin of the roulette wheel," where outcomes can be unpredictable despite careful preparation 6. To mitigate risks, Sam suggests using a trained guide who can provide support and intervention if needed, emphasizing that not all unpleasant experiences are ultimately negative 2.

Related Episodes